HSC Section 8_April 2017

Otolaryngology–Head and Neck Surgery 151(1)

worth mentioning that neither technetium nor gallium scans were routinely used for diagnosis or monitoring of disease; thus, it is possible that some patients with clinical and radio- graphic evidence of resolution may have in fact had ongoing infections. Finally, because many of our patients travel long distances for care at our center, they often elect to follow up with their local otolaryngologists after the completion of treatment and apparent resolution of their infections. This precluded us from following outcomes for the majority of the patients in our study beyond 1 month after the comple- tion of antibiotic therapy. Conclusions Our study underscores the increasing frequency of non- Pseudomonas causes of MOE and specifically highlights that MRSA is an increasingly important organism leading to MOE. A high index of suspicion for atypical organisms, such as MRSA, should be maintained in patients with signs and symptoms of MOE who do not have diabetes. Candace E. Hobson , Data acquisition and analysis, interpretation of data, drafting of manuscript, final approval; Jennifer D. Moy , data acquisition, critical revision of manuscript, final approval; Karin E. Byers , Study conception and design, critical revision of manuscript, final approval; Yael Raz , study conception and design, critical revision of manuscript, final approval; Barry E. Hirsch , study conception and design, critical revision of manuscript, final approval; Andrew A. McCall , study conception and design, analy- sis and interpretation of data, drafting and critical revision of manuscript, final approval. Author Contributions

3. Rubin J, Yu VL. Malignant external otitis: insights into patho- genesis, clinical manifestations, diagnosis, and therapy. Am J Med . 1988;85:391-398. 4. Bayardelle P, Jolivet-Granger M, Larochelle D. Staphylococcal malignant external otitis. Can Med Assoc J . 1982;126:155-156. 5. Ali T, Meade K, Anari S, ElBadawey MR, Zammit-Maempel I. Malignant otitis externa: case series. J Laryngol Otol . 2010; 124:846-851. 6. Soudry E, Hamzany Y, Preis M, Joshua B, Hadar T, Nageris BI. Malignant external otitis: analysis of severe cases. Otolaryngol Head Neck Surg . 2011;144:758-762. 7. Chen CN, Chen YS, Yeh TH, Hsu CJ, Tseng FY. Outcomes of malignant external otitis: survival vs mortality. Acta Otolaryngol . 2010;130:89-94. 8. Yu LH, Shu CH, Tu TY, Shiao AS, Lien CF. Malignant otitis externa. Chin Med J . 1999;62:362-368. 9. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin- resistant S. aureus infections among patients in the emergency department. N Engl J Med . 2006;355:666-674. 10. Cohen D, Friedman P. The diagnostic criteria of malignant external otitis. J Laryngol Otol . 1987;101:216-221. 11. Mehrotra P, Elbadawey MR, Zammit-Maempel I. Spectrum of radiological appearances of necrotising external otitis: a pictor- ial review. J Laryngol Otol . 2011;125:1109-1115. 12. Joshua BZ, Sulkes J, Raveh E, Bishara J, Nageris BI. Predicting outcome of malignant external otitis. Otol Neurotol . 2008;29:339-343. 13. Jacobsen LM, Antonelli PJ. Errors in the diagnosis and man- agement of necrotizing otitis externa. Otolaryngol Head Neck Surg . 2010;143:506-509. 14. Bernstein JM, Holland NJ, Porter GC, Maw AR. Resistance of Pseudomonas to ciprofloxacin: implications for the treatment of malignant otitis externa. J Laryngol Otol . 2007;121:118-123. 15. Berenholz L, Katzenell U, Harell M. Evolving resistant pseudo- monas to ciprofloxacin in malignant otitis externa. Laryngoscope . 2002;112:1619-1622. 16. Elamurugan TP, Jagdish S, Kate V, Chandra Parija S. Role of bone biopsy specimen culture in the management of diabetic foot osteomyelitis. Int J Surg . 2011;9:214-216.

Disclosures Competing interests: None. Sponsorships: None. Funding source: None.

References

1. Meltzer PE, Keleman G. Pyocyaneous osteomyelitis of the tem- poral bone, mandible and zygoma. Laryngoscope . 1959;69:1300. 2. Chandler JR. Malignant external otitis. Laryngoscope . 1968; 78:1257-1294.

87